Sab Biotherapeutics Stock Technical Analysis

SABS Stock  USD 4.39  0.10  2.33%   
As of the 23rd of April, SAB Biotherapeutics owns the Market Risk Adjusted Performance of 0.6313, information ratio of (0.1), and Coefficient Of Variation of (1,259). In respect to fundamental indicators, the technical analysis model makes it possible for you to check possible technical drivers of SAB Biotherapeutics, as well as the relationship between them. Strictly speaking, you can use this information to find out if the entity will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We have analyzed thirteen technical drivers for SAB Biotherapeutics, which can be compared to its peers in the sector. Please validate SAB Biotherapeutics mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if SAB Biotherapeutics is priced fairly, providing market reflects its prevailing price of 4.39 per share. Given that SAB Biotherapeutics has information ratio of (0.1), we advise you to double-check SAB Biotherapeutics's latest market performance to make sure the company can sustain itself in the future.

SAB Biotherapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as SAB, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SAB
  
SAB Biotherapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

SAB Biotherapeutics Analyst Consensus

Target PriceAdvice# of Analysts
2.3Strong Buy2Odds
SAB Biotherapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most SAB analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand SAB stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of SAB Biotherapeutics, talking to its executives and customers, or listening to SAB conference calls.
SAB Analyst Advice Details
SAB Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of SAB Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of SAB Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

SAB Biotherapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of SAB Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

SAB Biotherapeutics Trend Analysis

Use this graph to draw trend lines for SAB Biotherapeutics. You can use it to identify possible trend reversals for SAB Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual SAB Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

SAB Biotherapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for SAB Biotherapeutics applied against its price change over selected period. The best fit line has a slop of   0.03  , which may suggest that SAB Biotherapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 25.61, which is the sum of squared deviations for the predicted SAB Biotherapeutics price change compared to its average price change.

About SAB Biotherapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of SAB Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of SAB Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on SAB Biotherapeutics price pattern first instead of the macroeconomic environment surrounding SAB Biotherapeutics. By analyzing SAB Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of SAB Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to SAB Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Graham Number44.9926.2942.2426.62
Receivables Turnover7.64.33.873.16

SAB Biotherapeutics April 23, 2024 Technical Indicators

Most technical analysis of SAB help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for SAB from various momentum indicators to cycle indicators. When you analyze SAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether SAB Biotherapeutics is a strong investment it is important to analyze SAB Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact SAB Biotherapeutics' future performance. For an informed investment choice regarding SAB Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SAB Biotherapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy SAB Stock please use our How to Invest in SAB Biotherapeutics guide.
Note that the SAB Biotherapeutics information on this page should be used as a complementary analysis to other SAB Biotherapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for SAB Stock analysis

When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is SAB Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SAB Biotherapeutics. If investors know SAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SAB Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.60)
Earnings Share
(7.64)
Revenue Per Share
0.406
Quarterly Revenue Growth
(0.86)
Return On Assets
(0.35)
The market value of SAB Biotherapeutics is measured differently than its book value, which is the value of SAB that is recorded on the company's balance sheet. Investors also form their own opinion of SAB Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is SAB Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SAB Biotherapeutics' market value can be influenced by many factors that don't directly affect SAB Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SAB Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SAB Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SAB Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.